KARUNA THERAPEUTICS INC's ticker is KRTX and the CUSIP is 48576A100. A total of 101 filers reported holding KARUNA THERAPEUTICS INC in Q1 2020. The put-call ratio across all filers is 8.88 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $1,274,817 | -37.9% | 7,539 | -20.4% | 0.00% | -50.0% |
Q2 2023 | $2,053,602 | +15.9% | 9,470 | -2.9% | 0.00% | +33.3% |
Q1 2023 | $1,771,865 | -6.7% | 9,755 | +0.9% | 0.00% | -25.0% |
Q4 2022 | $1,899,760 | -28.7% | 9,668 | -18.3% | 0.00% | -33.3% |
Q3 2022 | $2,663,000 | +386.8% | 11,840 | +174.0% | 0.01% | +500.0% |
Q2 2022 | $547,000 | +35.4% | 4,321 | +35.7% | 0.00% | 0.0% |
Q1 2022 | $404,000 | -35.2% | 3,184 | -33.1% | 0.00% | 0.0% |
Q4 2021 | $623,000 | +41.9% | 4,756 | +32.5% | 0.00% | 0.0% |
Q3 2021 | $439,000 | +5.3% | 3,589 | -1.8% | 0.00% | 0.0% |
Q2 2021 | $417,000 | -22.5% | 3,656 | -18.2% | 0.00% | 0.0% |
Q1 2021 | $538,000 | -0.4% | 4,472 | -15.9% | 0.00% | 0.0% |
Q4 2020 | $540,000 | +11.8% | 5,319 | -14.9% | 0.00% | 0.0% |
Q3 2020 | $483,000 | -58.8% | 6,249 | -40.5% | 0.00% | -75.0% |
Q2 2020 | $1,172,000 | +51.0% | 10,509 | -2.5% | 0.00% | +33.3% |
Q1 2020 | $776,000 | +20.1% | 10,778 | +25.8% | 0.00% | +50.0% |
Q4 2019 | $646,000 | – | 8,569 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Sofinnova Investments, Inc. | 1,952,441 | $150,963,000 | 11.19% |
Eventide Asset Management | 901,077 | $69,671,000 | 1.36% |
First Light Asset Management, LLC | 128,200 | $9,912,000 | 1.02% |
Prosight Management, LP | 15,826 | $1,224,000 | 0.58% |
MOODY ALDRICH PARTNERS LLC | 30,970 | $2,395,000 | 0.50% |
PFM Health Sciences, LP | 137,960 | $10,667,000 | 0.49% |
Rock Springs Capital Management LP | 244,106 | $18,874,000 | 0.48% |
Atika Capital Management LLC | 73,500 | $5,683,000 | 0.46% |
Hood River Capital Management LLC | 132,400 | $10,237,000 | 0.44% |
CATALYST PRIVATE WEALTH, LLC | 5,006 | $387,000 | 0.38% |